Alzheimer's Association awards $4.3 million to accelerate the launch of new drug treatment

(Alzheimer's Association) The Alzheimer's Association announces a new $4.3 million research grant for a new phase of the Dominantly Inherited Alzheimer's Network Trials Unit known as DIAN-TU Next Generation. This award will accelerate the testing of new potential Alzheimer's therapies and a new diagnostic approach in people with genetically based, younger-onset Alzheimer's disease using an innovative trial design that is being applied to Alzheimer's for the first time.